You are using an unsupported browser. Please update your browser to the latest version on or before July 31, 2020.
close

Showing articles from Drug development tag

Rare Therapies: Pharmacological Chaperones and Cell Therapies

[Rare Therapies:Pharmacological Chaperones and Cell Therapies][1] from [Global Genes][2] on [Vimeo][3]. [1]: https://vimeo.com/296062224 [2]: https://vimeo.com/globalgenes [3]: https://vimeo.com

Update from the Community: Patient-Focused Drug Development Meetings

[Update from the Community: Patient-Focused Drug Development Meetings][1] from [Global Genes][2] on [Vimeo][3]. [1]: https://vimeo.com/295913900 [2]: https://vimeo.com/globalgenes [3]: https://vimeo.com

Summit Day 2: Session 4- Patient-Centered Benefit-Risk Assessment: Why It Matters To You

[Summit Day 2: Session 4- Patient-Centered Benefit-Risk Assessment: Why It Matters To You][1] from [Global Genes][2] on [Vimeo][3]. [1]: https://vimeo.com/107208634 [2]: https://vimeo.com/globalgenes [3]: https://vimeo.com

Summit Day 2: Session 4- Deep Dive, Mobilizing Your Community For Patient-Focused Drug Development

[Summit Day 2: Session 4- Deep Dive, Mobilizing Your Community For Patient- Focused Drug Development][1] from [Global Genes][2] on [Vimeo][3]. [1]: https://vimeo.com/107276743 [2]: https://vimeo.com/globalgenes [3]: https://vimeo.com

The Value of Rare Disease Therapies: Patient Perspectives Needed

There is a lot of public debate surrounding the value of rare disease therapies. How do we ensure that the perspectives of patients, families, and advocates are included in these discussions and assessments? Advocates and economic experts will discuss new thoughts on the value of therapies and how advocates can get in…

Patients and Caregivers: Shaping Clinical Drug Development

Starting a clinical trial is no simple task. From developing a protocol to patient recruitment to U.S. Food and Drug Administration (FDA) submission, there are a wide array of complex and closely monitored processes along the way. Patient and community involvement help ensure study questions are relevant and that the …

Global Genes LIVE!: Mapping Patient Inclusion in Drug Development

Are you in the early stages of learning how to engage in the drug development process as an organization or individual patient? Then join us to get a strong understanding of the drug discovery and preclinical development processes. We will discuss the lifecycle of traditional therapies and new trends in research and d…

scroll to top icon